contraception and thereby to improve continuation rates (Fraser, 1983) .
It has been suggested that the administration of an anti-
It has been demonstrated that the addition of an antiprogesterprogesterone might improve bleeding patterns in women one to progestin-only contraception reduces the incidence of with irregular bleeding while using low-dose progestinunscheduled bleeding in monkeys (Williams et al., 1997) . In only contraception. We report the findings of a doublea small pilot study among women using Norplant ® , we have blind, randomized, placebo-controlled trial of mifepristone demonstrated that a single dose of mifepristone 200 mg induces 50 mg taken once every 4 weeks in 100 Chinese women changes in endometrial progesterone and oestrogen receptors (50 subjects and 50 controls) complaining of frequent and which are consistent with the functional inhibition of progesterirregular bleeding while using a levonorgestrel-releasing one. There was a suggestion that anti-progesterone treatment subdermal contraceptive implant. In all women, regardless might improve bleeding patterns, either by a direct effect on of treatment, the frequency of bleeding decreased significthe endometrium or by inducing ovulation (Wang et al., 1997) .
antly over 360 days of observation. Women recorded
In an attempt to see whether the monthly administration of a significantly shorter episodes of bleeding (P < 0.0002) single dose of anti-progesterone might confer a clinically during mifepristone treatment than during the 90 days significant improvement in bleeding patterns, we undertook a before treatment started. In contrast, the duration of double-blind randomized trial of once a month administration bleeding episodes fell more gradually in placebo-treated of mifepristone to women using the Chinese levonorgestrelcontrols. Women using mifepristone were more likely to releasing implant (Sino-implant). find treatment acceptable than women receiving a placebo None of the authors has any vested interests of a commercial tablet (P < 0.01). Despite concern that anti-progestogenic nature relevant to this study. effects may jeopardize contraception, there were no pregnancies. This approach may offer a useful strategy to improve continuation rates by alleviating unwanted sideMaterials and methods effects until bleeding patterns improve spontaneously One hundred women aged 18-40 years were recruited from three with time.
family planning clinics on the outskirts of Shanghai. All had been Introduction as a bleeding episode occurring more often than once every 24 days. None was receiving any medication and all were fit and well with Progestin-only contraceptive implants offer highly effective no history of any gynaecological disease. Local ethical committee contraception that is long-acting and does not require compliapproval was obtained for the study and informed consent was given ance for effectiveness. The major side-effect is an irregular by all participants.
pattern of uterine bleeding (Fraser et al., 1998) . At the end of Women were randomized (50 in each group), using random number All women were instructed to keep a daily diary of bleeding and (41) 20 (41) treatment women were given a date to return to the clinic once every 28 days for 5 months (a total of six treatments in all). Treatment was always given at the family planning clinic, where pill taking was controls). All women completed the study and there were no observed by a doctor after urinary β-human chorionic gonadotrophin pregnancies.
(HCG) had been measured to exclude pregnancy. At this visit the
The effect of treatment on bleeding patterns is shown in bleeding diary was checked. Bleeding diaries were continued for a of bleeding episodes also fell significantly with time from 15
In the final analysis, bleeding and spotting days were combined days during the 90 days before treatment to 11.1 days at the and the data analysed using the Mann-Whitney U-test.
end of the first 90 days of treatment (P ϭ 0.0003) and 8.2 days after the completion of all six treatment cycles. The mean Results duration of bleeding episodes almost halved for both groups of women when the number during the pre-treatment period There were no differences in age (29.5 years for subjects, 30 years for controls) or parity (2.6 for each group) between was compared with that post-treatment, regardless of whether they had been treated with placebo or mifepristone. subjects and controls nor in the mean duration of implant use (15.8 Ϯ 2 months for subjects and 16.5 Ϯ 2 months for Forty-eight subjects and 49 controls completed the post- treatment satisfaction questionnaire. Women treated with bleeding episodes was reduced to a similar extent regardless of treatment. This tendency for bleeding patterns to improve mifepristone were more likely to rate their treatment as has been observed with Norplant (Shoupe et al., 1991) and satisfactory than those who received placebo (P Ͻ 0.01, has been attributed to an increase in the frequency of ovulation Table I ).
as concentrations of levonorgestrel delivered by the implant gradually fall. We analysed the number of bleeding and spotting Discussion days and number of bleeding episodes (among both subjects In all women using the Sino-implant, bleeding patterns and controls and both groups combined), comparing women improved during the 360 days of follow-up. The number of who had been using the implants for durations of less than bleeding days decreased (and inevitably therefore the number the median with those who had been using them for longer than the median duration for the group. While there did appear of dry days increased) and both the number and duration of to be a slight improvement (Table II) , the differences were not because they do not like -or cannot remember -to take a pill every day. Further, and more detailed, studies of the statistically significant, in contrast to the differences seen in response to mifepristone administration. The incidence of sidemechanism of action of this regimen are warranted. effects also has been reported to decrease with time among women using the Sino-implant (Fang et al., 1998) , although References whether this is due to an increase in ovulatory cycles is ovarian activity, need to be undertaken.
Reprod., 11, 165-178.
While these results may seem somewhat disappointing, the Fraser, I.S., Tiitinen, A., Affandi, B. et al. (1998) Norplant ® consensus statement and background review. Contraception, 57, 1-9.
women clearly found mifepristone to be of benefit. It hardly Hickey, M., Simbar, M., Markham, R. et al. (1999a) Changes in endothelial needs scientific methodology to confirm that a bleeding episode cell basement membrane in Norplant users. Hum. Reprod., 14, [716] [717] [718] [719] [720] [721] of shorter duration has to be more acceptable than one that Hickey, M., Simbar, M., Markham, R. et al. (1999b) Fertil. Steril., 55, [766] [767] [768] [769] [770] ging the quality of cervical mucus and inhibiting normal sperm Sivin, I., Mishell, D.R. Jr, Darney, P. et al. (1998) Efficacy, side effects and penetration (Croxatto et al., 1987) . Abnormal endometrial acceptability of soft tubing Norplant ® implants in the United States: a 5-year study. Obstet. Gynecol., 92, [337] [338] [339] [340] [341] [342] [343] [344] development will prevent implantation, should fertilization effects of the progestogen, mifepristone itself at a dose of 50 Regulation (1996) Clinical evaluation of the therapeutic effectiveness of mg has both contraceptive and abortifacient effects and the ethinyl oestradiol and oestrone sulphate on prolonged bleeding in women risk of pregnancy may in fact be reduced still further. using depot medroxyprogesterone acetate for contraception. Hum. Reprod., 11, 1-13.
The results of this study suggest that the once a month administration of mifepristone may be an effective and acceptReceived on December 20, 1999; accepted on May 23, 2000 able way to ameliorate bleeding irregularities and 'tide women over' until bleeding patterns improve with time as a consequence of an increasing frequency of ovulatory cycles. It is possible to achieve a similar effect with the combined oral contraceptive pill (Diaz et al., 1990) , but most women find the idea of using two hormonal contraceptives simultaneously hard to understand and many have chosen a long-acting implant
